Recombinant human Fibroblast activation protein, alpha (His tag C-Terminus)
Be the first to review this product! Submit a review
|
(1 Publication)
Recombinant human Fibroblast activation protein, alpha is a Human Fragment protein, in the 29 to 760 aa range, expressed in Baculovirus infected Sf9, with >90% purity and suitable for SDS-PAGE and Functional studies. The predicted molecular weight of ab79623 protein is 86 kDa.
- Save time and ensure accurate results - use our Fibroblast Activation Protein (FAP) protein as a control
- Optimal protein bioactivity, stability and reproducibility
View Alternative Names
Prolyl endopeptidase FAP, 170 kDa melanoma membrane-bound gelatinase, Dipeptidyl peptidase FAP, Fibroblast activation protein alpha, Gelatine degradation protease FAP, Integral membrane serine protease, Post-proline cleaving enzyme, Serine integral membrane protease, Surface-expressed protease, FAPalpha, SIMP, Seprase, FAP
- FuncS
Unknown
Functional Studies - Recombinant human Fibroblast activation protein, alpha (His tag C-Terminus) (AB79623)
Image showing specific activity of ab79623.
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant human Fibroblast activation protein, alpha (His tag C-Terminus) (AB79623)
SDS-PAGE showing 3ug ab79623 at approximately 85.5kDa.
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Specifications
Form
Liquid
Additional notes
Affinity purified.
General info
Function
Cell surface glycoprotein serine protease that participates in extracellular matrix degradation and involved in many cellular processes including tissue remodeling, fibrosis, wound healing, inflammation and tumor growth. Both plasma membrane and soluble forms exhibit post-proline cleaving endopeptidase activity, with a marked preference for Ala/Ser-Gly-Pro-Ser/Asn/Ala consensus sequences, on substrate such as alpha-2-antiplasmin SERPINF2 and SPRY2 (PubMed : 14751930, PubMed : 16223769, PubMed : 16410248, PubMed : 16480718, PubMed : 17381073, PubMed : 18095711, PubMed : 21288888, PubMed : 24371721). Degrade also gelatin, heat-denatured type I collagen, but not native collagen type I and IV, vitronectin, tenascin, laminin, fibronectin, fibrin or casein (PubMed : 10347120, PubMed : 10455171, PubMed : 12376466, PubMed : 16223769, PubMed : 16651416, PubMed : 18095711, PubMed : 2172980, PubMed : 7923219, PubMed : 9065413). Also has dipeptidyl peptidase activity, exhibiting the ability to hydrolyze the prolyl bond two residues from the N-terminus of synthetic dipeptide substrates provided that the penultimate residue is proline, with a preference for Ala-Pro, Ile-Pro, Gly-Pro, Arg-Pro and Pro-Pro (PubMed : 10347120, PubMed : 10593948, PubMed : 16175601, PubMed : 16223769, PubMed : 16410248, PubMed : 16651416, PubMed : 17381073, PubMed : 21314817, PubMed : 24371721, PubMed : 24717288). Natural neuropeptide hormones for dipeptidyl peptidase are the neuropeptide Y (NPY), peptide YY (PYY), substance P (TAC1) and brain natriuretic peptide 32 (NPPB) (PubMed : 21314817). The plasma membrane form, in association with either DPP4, PLAUR or integrins, is involved in the pericellular proteolysis of the extracellular matrix (ECM), and hence promotes cell adhesion, migration and invasion through the ECM. Plays a role in tissue remodeling during development and wound healing. Participates in the cell invasiveness towards the ECM in malignant melanoma cancers. Enhances tumor growth progression by increasing angiogenesis, collagen fiber degradation and apoptosis and by reducing antitumor response of the immune system. Promotes glioma cell invasion through the brain parenchyma by degrading the proteoglycan brevican. Acts as a tumor suppressor in melanocytic cells through regulation of cell proliferation and survival in a serine protease activity-independent manner.
Sequence similarities
Belongs to the peptidase S9B family.
Post-translational modifications
N-glycosylated.. The N-terminus may be blocked.
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in veterinary science 11:1416124 PubMed39188902
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com